50 min
Conversation with Peter A. Schneider, M.D. and Justin Klein, M.D., J.D. Medtech POV with Scott Whitaker
-
- Business
Dr. Peter Schneider, Professor of Surgery in the Division of Vascular & Endovascular Surgery at the University of California San Francisco, and Dr. Justin Klein, AdvaMed board member and co-founder at Vensana Capital joined Medtech POV to talk about a recent New York Times story about atherectomies and peripheral artery disease (PAD) and the impact the story could have on patients seeking treatment for this condition.
AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. Learn more: www.advamed.org
Dr. Peter Schneider, Professor of Surgery in the Division of Vascular & Endovascular Surgery at the University of California San Francisco, and Dr. Justin Klein, AdvaMed board member and co-founder at Vensana Capital joined Medtech POV to talk about a recent New York Times story about atherectomies and peripheral artery disease (PAD) and the impact the story could have on patients seeking treatment for this condition.
AdvaMed, the Medtech Association, is the world's largest trade association for the medical technology industry, representing nearly 500 companies around the world that are developing life-changing and life-saving medical technologies for patients. Learn more: www.advamed.org
50 min